昆作为神经保护剂
Ángel Cores1, Noelia Carmona-Zafra1, José Clerigué1
1Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, Plaza de Ramón y Cajal sn, 28040 Madrid, Spain.
Antioxidants (Basel, Switzerland)
|July 29, 2023
概括
昆在神经退行性疾病治疗中具有双重作用,既能起保护作用,又能起有毒作用. 低剂量激活细胞保护的途径,而各种天然和合成素显示神经保护的潜力.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 昆在神经退行性疾病中表现出双重的细胞保护和细胞毒性作用.
- 低剂量,中度电友性类激素激活Keap1/Nrf2通路,诱导排毒酶.
- 像辅酶Q10这样的天然子对细胞能量至关重要,并表现出神经保护作用.
研究的目的:
- 探索金在神经退行性疾病治疗中的多方面的作用.
- 识别和分类具有神经保护性质的天然和合成.
- 要突出基因因因诱导细胞保护的机制.
主要方法:
- 文献综述和对子生物活性现有研究的分析.
- 基于其来源 (内源性/非内源性) 和结构相似性的类的分类.
- 检查与细胞通路的相互作用,特别是Keap1/Nrf2.
主要成果:
- 同酶Q10,伊多本,密托金和塑金显示出与阿尔茨海默氏症和帕金森病有关的神经保护作用.
- 托科菲醇衍生的 (例如,瓦提基) 和维生素K也表现出神经保护作用.
- 不同的非内源性子,包括恩贝林,APX-3330和混合结构,显示出潜在的神经保护益处.
结论:
- 昆代表了神经退行性疾病治疗的一类有前途的化合物.
- 了解子的剂量依赖性和结构细微差别对于治疗开发至关重要.
- 对新衍生物和混合结构的进一步研究可能会产生有效的治疗方法.
相关概念视频
Oxidation of Phenols to Quinones
3.1K
In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.1K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
155
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
The Electron Transport Chain
16.9K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.9K
Anticholinesterase Agents: Poisoning and Treatment
921
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
921
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
346
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
346


